Charles River Laboratories International (CRL) Revenue — Quarter Ended Jul 1, 2023
Revenue increased compared to the immediately preceding quarter and the same quarter one year earlier. The company reported higher revenue for the period.
Key takeaway
Quarter ended Jul 1, 2023 · FY2023 Q2
Revenue increased compared to the immediately preceding quarter and the same quarter one year earlier. The company reported higher revenue for the period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+3.0%
Change from the immediately preceding quarter.
Year-over-year
+8.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 24, 2022 | $989.2M | +10.4% |
| Dec 31, 2022 | $1.1B | +21.5% |
| Apr 1, 2023 | $1B | +12.6% |
| Jul 1, 2023 | $1.1B | +8.9% |
Revenue performance
Revenue for the quarter rose, reflecting a positive trend from the prior period and the comparable prior-year quarter.
Quarterly comparison
Compared with the preceding quarter, revenue improved, and it also showed growth when compared with the same quarter last year.
What to watch
The filing notes risks related to non-human primate supply chain and ongoing U.S. government investigations.